Baxalta Pharmaceutical Company receives positive EMA decision on paediatric investigation plan (PIP) for leniolisib in Europe Read more
Baxalta Pharmaceutical Company and Sanofi renew strategic manufacturing partnership agreement Read more
Baxalta Pharmaceutical Company reports financial results for the first nine months of 2021 Read more

Current pipeline

Current pipelines


Upcoming Events

View our financial calendar and what conferences, meetings, and congresses we will visit in 2022 on our upcoming events page.

Read more
Latest corporate presentation

Baxalta Pharmaceutical Company announced its 9 month financial results and held a presentation for analysts on Thursday 28 October 2021. To watch the recording of the presentation please follow the link below.

Read more